Press Release 2023 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sami-Sabinsa Opens Office in France, Appoints Ms. Nathalie Allaume as Sales Manager

Sabinsa on Wheels Science Seminars Return at PCI Days Expo XXI in Warsaw, Poland

Sami-Sabinsa Wins 2023 Technology Innovation Award in China for LactoSpore®

Sami-Sabinsa Group Commits to Clean, Renewable Energy : Captive solar energy will power five manufacturing plants

Two New Healthy Aging Clinical Studies on Sabinsa’s Curcumin C3 Complex® Published

Sabinsa EU to Showcase Innovative, Science-backed Ingredients At Vitafoods Europe 2023

Certificates

Global Offices

Get in Touch

Disclaimer